EE200300061A - Perfluoroalküülrühmi sisaldavad metallikompleksidkasutamiseks kontrastainetena magnetresonantskuvamisel naastude, kasvajate ja nekrooside visualiseerimiseks - Google Patents

Perfluoroalküülrühmi sisaldavad metallikompleksidkasutamiseks kontrastainetena magnetresonantskuvamisel naastude, kasvajate ja nekrooside visualiseerimiseks

Info

Publication number
EE200300061A
EE200300061A EEP200300061A EEP200300061A EE200300061A EE 200300061 A EE200300061 A EE 200300061A EE P200300061 A EEP200300061 A EE P200300061A EE P200300061 A EEP200300061 A EE P200300061A EE 200300061 A EE200300061 A EE 200300061A
Authority
EE
Estonia
Prior art keywords
plaques
necrosis
tumors
magnetic resonance
resonance imaging
Prior art date
Application number
EEP200300061A
Other languages
English (en)
Inventor
Platzek Johannes
Mareski Peter
Niedballa Ulrich
Rad�chel Bernd
Weinmann Hanns-Joachim
Misselwitz Bernd
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10040380A external-priority patent/DE10040380B4/de
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of EE200300061A publication Critical patent/EE200300061A/et

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806Suspensions, emulsions, colloids, dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA

Landscapes

  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
EEP200300061A 2000-08-11 2001-07-23 Perfluoroalküülrühmi sisaldavad metallikompleksidkasutamiseks kontrastainetena magnetresonantskuvamisel naastude, kasvajate ja nekrooside visualiseerimiseks EE200300061A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10040380A DE10040380B4 (de) 2000-08-11 2000-08-11 Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Plaques
PCT/EP2001/008498 WO2002013874A2 (de) 2000-08-11 2001-07-23 Verwendung von perfluoralkylhaltigen metallkomplexen als kontrastmittel im mr-imaging zur darstellung von plaques, tumoren und nekrosen

Publications (1)

Publication Number Publication Date
EE200300061A true EE200300061A (et) 2004-12-15

Family

ID=7652860

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300061A EE200300061A (et) 2000-08-11 2001-07-23 Perfluoroalküülrühmi sisaldavad metallikompleksidkasutamiseks kontrastainetena magnetresonantskuvamisel naastude, kasvajate ja nekrooside visualiseerimiseks

Country Status (26)

Country Link
EP (1) EP1307236A2 (et)
JP (1) JP2004506025A (et)
KR (1) KR20030022387A (et)
CN (1) CN1469757A (et)
AR (1) AR034139A1 (et)
AU (2) AU2001277549B2 (et)
BG (1) BG107542A (et)
BR (1) BR0113188A (et)
CA (1) CA2419223A1 (et)
CZ (1) CZ2003392A3 (et)
DE (1) DE10066210B4 (et)
EE (1) EE200300061A (et)
HR (1) HRP20030173A2 (et)
HU (1) HUP0300736A3 (et)
IL (1) IL154385A0 (et)
MX (1) MXPA03001287A (et)
NO (1) NO20030604L (et)
NZ (1) NZ523932A (et)
PL (1) PL365596A1 (et)
RU (1) RU2290206C2 (et)
SK (1) SK1572003A3 (et)
TW (1) TWI296931B (et)
UA (1) UA82642C2 (et)
WO (1) WO2002013874A2 (et)
YU (1) YU10603A (et)
ZA (1) ZA200301949B (et)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344704B2 (en) 2002-07-10 2008-03-18 Schering Ag Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi
DE10231799B4 (de) * 2002-07-10 2006-10-05 Schering Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Intravasalen Thromben
DE102005008309A1 (de) * 2005-02-17 2006-08-24 Schering Ag Pharmazeutische Mittel enthaltend fluoralkylhaltige Metallkomplexe und Epothilone
DE102006021495A1 (de) * 2006-05-09 2007-11-15 Bayer Schering Pharma Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel zur Diagnose der Alzheimer Krankheit
US7887835B2 (en) * 2006-09-19 2011-02-15 Fujifilm Corporation Compound comprising a fluorine-substituted alkyl group and a liposome contrast medium comprising the compound
DE102006049821A1 (de) 2006-10-18 2008-04-24 Bayer Schering Pharma Aktiengesellschaft Metallchelate mit perfluoriertem PEG-Rest, Verfahren zu deren Herstellung, sowie deren Verwendung
DE102007015598A1 (de) * 2007-03-29 2008-10-02 Heinrich-Heine-Universität Düsseldorf Verwendung von fluorhaltigen Verbindungen zu Diagnosezwecken mit Hilfe bildgebender Verfahren
JP2011190183A (ja) * 2010-03-11 2011-09-29 Noguchi Institute フルオラス化糖結合型クラウンエーテル誘導体
US9976072B2 (en) * 2014-03-26 2018-05-22 Chevron U.S.A. Inc. Multicarboxylate compositions and method of making the same
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
JP7037069B2 (ja) * 2016-09-14 2022-03-16 ダイキン工業株式会社 分枝含フッ素化合物
ES2814555T3 (es) 2016-11-28 2021-03-29 Bayer Pharma AG Compuestos de quelato de gadolinio con alta relaxividad para usar en la obtención de imágenes por resonancia magnética
KR102934987B1 (ko) 2018-11-23 2026-03-09 바이엘 악티엔게젤샤프트 조영 매체의 제형 및 그의 제조 방법
CN109867635A (zh) * 2019-02-14 2019-06-11 华东师范大学 一种t1型胶束磁共振成像造影剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995009856A1 (en) * 1993-10-01 1995-04-13 The Regents Of The University Of California Boronated metalloporphyrins and therapeutic methods
US5502094A (en) * 1994-05-20 1996-03-26 Minnesota Mining And Manufacturing Company Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods for use
DE19603033A1 (de) * 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
JPH10112939A (ja) * 1996-10-07 1998-04-28 Nec Corp 電源切替回路
DE19729013A1 (de) * 1997-07-03 1999-02-04 Schering Ag Oligomere, perfluoralkylhaltige Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
US6019959A (en) * 1997-07-31 2000-02-01 Schering Aktiengesellschaft Oligomeric compounds that contain perfluoroalkyl, process for their production, and their use in NMR diagnosis

Also Published As

Publication number Publication date
NO20030604L (no) 2003-04-11
JP2004506025A (ja) 2004-02-26
IL154385A0 (en) 2003-09-17
RU2290206C2 (ru) 2006-12-27
HUP0300736A3 (en) 2010-01-28
WO2002013874A8 (de) 2002-06-13
AU7754901A (en) 2002-02-25
MXPA03001287A (es) 2003-10-06
NO20030604D0 (no) 2003-02-07
SK1572003A3 (en) 2003-10-07
AR034139A1 (es) 2004-02-04
NZ523932A (en) 2007-07-27
KR20030022387A (ko) 2003-03-15
HRP20030173A2 (en) 2005-04-30
DE10066210B4 (de) 2008-02-28
CN1469757A (zh) 2004-01-21
BR0113188A (pt) 2003-06-24
PL365596A1 (en) 2005-01-10
WO2002013874A2 (de) 2002-02-21
BG107542A (bg) 2003-09-30
EP1307236A2 (de) 2003-05-07
HUP0300736A2 (hu) 2003-09-29
TWI296931B (en) 2008-05-21
CZ2003392A3 (cs) 2003-09-17
CA2419223A1 (en) 2003-02-11
YU10603A (sh) 2006-05-25
ZA200301949B (en) 2004-12-14
UA82642C2 (uk) 2008-05-12
AU2001277549B2 (en) 2007-02-08

Similar Documents

Publication Publication Date Title
EE200300061A (et) Perfluoroalküülrühmi sisaldavad metallikompleksidkasutamiseks kontrastainetena magnetresonantskuvamisel naastude, kasvajate ja nekrooside visualiseerimiseks
EP1379885A4 (en) CONTRAST REINFORCING AGENT FOR MAGNETIC RESONANCE IMAGING
EP1171032A4 (en) PROCESS FOR IN VIVO IMAGING BY MAGNETIC RESONANCE
WO2000030688A3 (en) Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as mri contrast agents
SG108859A1 (en) Magnetic recording medium
SG108964A1 (en) Perpendicular magnetic recording medium
AU2003224374A1 (en) Reduction of susceptibility artifacts in subencoded single-shot magnetic resonance imaging
AU2003302229A8 (en) Imaging by magnetic resonance adsorption, elastography and tomography
GB2366800B (en) Antibody molecules having specificity for human tumor necrosis factor alpha,and use thereof
SG91343A1 (en) Perpendicular magnetic recording medium and magnetic recording apparatus
SG91345A1 (en) Perpendicular magnetic recording medium
EP1366710A4 (en) PARALLEL MR TOMOGRAPHY WITH HIGH PRECISION COIL SENSITIVITY MAP
DE60013651D1 (de) Magnetisches Aufzeichnungsmittel
AU2002256311A1 (en) Artifact suppression in dynamic magnetic resonance imaging
ITMI20011708A0 (it) Coniugati di peptidi, loro derivati con complessi metallici e utilizzo per i'indagine diagnostica tramite imaging per risonanza magnetica(m
SG98071A1 (en) Perpendicular magnetic recording medium and magnetic recording apparatus
AU2001277549A1 (en) Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses
NO20004561D0 (no) Metode for magnetisk resonansavbildning
SG111962A1 (en) Magnetic recording medium
SG116459A1 (en) Perpendicular magnetic recording medium.
GB2439857B (en) Shielded, asymmetric magnets for use in magnetic resonance imaging
EP1300111A4 (en) Magnetic resonance imaging apparatus
AU2003295288A8 (en) Magnetic resonance imaging method and compounds for use in the method
DE60230493D1 (de) Magnetisches aufzeichnungsmedium
SG122768A1 (en) Magnetic recording medium